Xenon Pharmaceuticals, Inc. (XENE)
52.79
+1.58
(+3.09%)
USD |
NASDAQ |
Jun 09, 16:00
52.79
0.00 (0.00%)
After-Hours: 17:37
Xenon Pharmaceuticals Shareholders Equity (Quarterly) : 1.338B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Praxis Precision Medicines, Inc. | 1.410B |
| Psyence Biomedical Ltd. | -- |
| AbbVie, Inc. | -6.656B |
| Aurinia Pharmaceuticals, Inc. | 567.63M |
| enGene Therapeutics, Inc. | 281.55M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.387B |
| Total Liabilities (Quarterly) | 48.99M |
| Debt to Equity Ratio | 0.0056 |
| Current Ratio | 27.79 |
| Net Debt Paydown Yield | 0.01% |